Related Experiment Video
Updated: Jun 28, 2026

13:32
Designing a Bio-responsive Robot from DNA Origami
Published on: July 8, 2013
DNA origami as a biomaterials platform for programming ligand-receptor interactions and cell fate
Xuemei Xu1,2, Yanyan Kong1, Zhuoran Mei1
1School of Chemical Engineering and Pharmacy, Wuhan Institute of Technology, Wuhan 430205, China.
Biomaterials Science
|June 26, 2026
Summary
DNA origami biomaterials precisely control ligand placement for cell signaling. This technology advances immunotherapy, drug delivery, and vaccine development with programmable nanoscale designs.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Molecular Biology
Background:
- DNA origami offers unprecedented precision in nanoscale spatial organization of ligands.
- Conventional biomaterials lack the geometric control for precise ligand arrangement.
- This technology enables systematic engineering of ligand valency, spacing, and nanopatterning.
Purpose of the Study:
- To review advances in DNA origami biomaterials for modulating cell signaling and fate.
- To explore the role of engineered ligand nanotopology in receptor activation and cellular responses.
- To highlight translational applications in medicine and biotechnology.
Main Methods:
- Utilizing DNA origami techniques to create precisely patterned ligand arrangements.
- Investigating the impact of engineered nanotopology on membrane receptor activation thresholds.
- Analyzing downstream signaling pathways and cellular fate decisions influenced by ligand nanopatterning.
Main Results:
- Engineered ligand nanotopology acts as a spatial switch for receptor activation.
- DNA origami enables orchestration of multi-receptor synergy and biomimetic antigen presentation.
- Demonstrated modulation of cellular responses including signaling and fate decisions.
Conclusions:
- DNA origami biomaterials provide a powerful platform for precise control over biological interactions at the nanoscale.
- These platforms show significant translational potential in immunotherapy, drug delivery, and vaccine development.
- Future directions include engineering intelligent DNA biomaterials for cross-scale biological regulation.

